文献速递心外重症与机械循环支持肺外科

肺动脉内膜剥脱术后大咯血短期VA-ECMO支持

Short-term venoarterial extracorporeal membrane oxygenation for massive endobronchial hemorrhage after pulmonary endarterectomy.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-09-20

该单中心回顾性研究纳入2014至2016年396例肺动脉内膜剥脱术患者,其中8例(2.0%)在脱离体外循环时发生严重支气管内出血,术中转为肝素涂层静脉-动脉ECMO并给予全剂量鱼精蛋白。ECMO支持平均49±13分钟,8例均成功脱机,7例出院、1例死亡。

要点

  • PEA脱机时严重支气管内出血可术中转VA-ECMO并全剂量鱼精蛋白逆转肝素。
  • 8例平均ECMO支持49±13分钟,均于手术室成功脱机且无再出血征象。

核心结论

  • 对PEA术后大支气管内出血患者,术中从CPB转为VA-ECMO并给予全剂量鱼精蛋白是可能挽救生命的治疗概念。

主要发现

  • 住院死亡率为2.3%(9/396例)。
  • 8例(2.0%)发生严重支气管内出血,支气管镜下弥漫型6例、局限型2例。
  • 8例平均ECMO支持49±13分钟,均于手术室成功脱机且无进一步支气管内出血征象。
  • 1例术后6小时因氧合差需静脉-静脉ECMO支持。
  • 7例术后延长住院后出院,住院时间17.6±4.1天;1例死亡。

临床怎么用

  • PEA脱机时出现严重支气管内出血,可考虑术中转为肝素涂层VA-ECMO并给予全剂量鱼精蛋白恢复凝血后尝试脱机。

局限性

  • 单中心回顾性研究,发生严重出血的样本量仅8例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pulmonary endarterectomy (PEA) is the only curative treatment option for patients with chronic thromboembolic pulmonary hypertension. Massive endobronchial bleeding that precludes weaning from cardiopulmonary bypass is an often-fatal complication of PEA. The aim of this study was to determine whether short-term extracorporeal membrane oxygenation (ECMO) is a safe and feasible procedure in patients with severe endobronchial bleeding. METHODS: From January 2014 to December 2016, 396 patients (mean age 60 ± 18 years, 54.5% male) underwent PEA in our department. Patients with severe endobronchial hemorrhage at the time of weaning from cardiopulmonary bypass (CPB) were switched to a heparin-coated venoarterial ECMO circuit. After full-dose protamine administration to restore normal coagulation, weaning from ECMO was attempted in the operating room. RESULTS: In-hospital mortality was 2.3% (9/396 patients). Eight patients (2.0%) developed severe endobronchial bleeding classified as diffuse (n = 6) or localized (n = 2) by bronchoscopy. After reinstitution of CPB and subsequent switch to ECMO, the mean duration of ECMO support was 49 ± 13 minutes, and all 8 patients were weaned successfully from ECMO in the operating theater without further signs of endobronchial bleeding. One patient needed venovenous ECMO support for poor oxygenation 6 hours after surgery. Seven patients were discharged after a prolonged postoperative stay of 17.6 ± 4.1 days. One patient died. This new concept significantly reduced mortality compared with previous (2009-2013) ECMO support (P = .0406). CONCLUSIONS: For patients with massive endobronchial bleeding after PEA, the intraoperative switch from CPB to venoarterial ECMO support with full-dose protamine administration is a new and potentially life-saving treatment concept.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Guth S, Wiedenroth CB, Wollenschläger M, et al. Short-term venoarterial extracorporeal membrane oxygenation for massive endobronchial hemorrhage after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2017. PMID: 29033041. doi:10.1016/j.jtcvs.2017.09.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。